Measurement of Antioxidant Activity and Oxidative Stress in Patients Undergoing Ophthalmic Surgery.

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Final enrollment: 60 participants — 6% of the 1000 planned Show 6 more changesShow less
    • Trial completed
    • Study completion date changed from estimate of Nov 2025 to Mar 29, 2026
    • Primary completion date changed from estimate of Nov 2025 to Oct 13, 2025
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 10 of 10 entries
    • Eligibility criteria expanded, about 5 words
  2. Start date changed from estimate of Dec 2024 to Mar 14, 2025
    • Publications: details revised at 10 of 10 entries
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial hypothesized that novel laser refractive surgery techniques (LASIK, KLEx) or laser-assisted cataract surgery (FLACAS) could suppress postoperative inflammation and improve recovery in patients by reducing oxidative stress generated by the surgical procedure. It is also intended to verify whether the new laser technology is necessary for clinical use in groups with low antioxidant activity through the detection of antioxidant activity in the eyes of patients.
Trial Details
NCT Number NCT06743594
Lead Sponsor Chang Gung Memorial Hospital
Collaborators: Taipei Nobel Eye Clinic
Conditions
(from sponsor)		 Cataract, Myopia
Related terms Cataract, Myopia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov